These final results, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the concept of concentrating on ACKR3 as a singular approach to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-relevant Conditions.We independently investi